corporate overview october 2006 jack armstrong president & ceo 1 this announcement contains forward looking statements within the meaning of private securities litigation reform act 1995 that are subject to risks and uncertainties known unknown reflect management s current views based on certain expectations assumptions such include among others regarding these preliminary results future clinical development plans prospects for genaera programs including evizon squalamine lomucin il9 antibody trodusquemine msi 1436 you may identify some by use words in as anticipate develop expect continue potential or other similar actual performance could differ materially from those currently anticipated expressed a result number risk factors but not limited history operating losses since inception its need additional funds operate business costs delays inherent scientific research drug trials regulatory approval process product candidates
